SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-011018
Filing Date
2021-02-02
Accepted
2021-02-02 17:21:31
Documents
12
Period of Report
2021-01-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm214858d1_8k.htm 8-K 26581
2 EXHIBIT 1.1 tm214858d1_ex1-1.htm EX-1.1 229607
3 EXHIBIT 4.1 tm214858d1_ex4-1.htm EX-4.1 117848
4 EXHIBIT 5.1 tm214858d1_ex5-1.htm EX-5.1 9368
5 EXHIBIT 10.1 tm214858d1_ex10-1.htm EX-10.1 167165
6 EXHIBIT 99.1 tm214858d1_ex99-1.htm EX-99.1 11248
7 EXHIBIT 99.2 tm214858d1_ex99-2.htm EX-99.2 12309
8 EXHIBIT 99.3 tm214858d1_ex99-3.htm EX-99.3 12317
9 GRAPHIC tm214858d1_ex5img001.jpg GRAPHIC 8432
10 GRAPHIC tm214858d1_ex5img002.jpg GRAPHIC 8259
11 GRAPHIC tm214858d1_ex99-1img004.jpg GRAPHIC 6535
12 GRAPHIC tm214858d1_ex99-2img005.jpg GRAPHIC 4011
  Complete submission text file 0001104659-21-011018.txt   625910
Mailing Address 4260 U.S. ROUTE 1 MONMOUTH JUNCTION NJ 08852
Business Address 4260 U.S. ROUTE 1 MONMOUTH JUNCTION NJ 08852 6096193990
Outlook Therapeutics, Inc. (Filer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37759 | Film No.: 21582753
SIC: 2836 Biological Products, (No Diagnostic Substances)